Relabeling the Medications We Call Antidepressants

This paper raises the question about whether the data on the medications we call antidepressants justify the label of antidepressant. The authors argue that a true antidepressant should be clearly superior to placebo, should offer a risk/benefit balance that exceeds that of alternative treatments, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Antonuccio, David, Healy, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820604/
https://www.ncbi.nlm.nih.gov/pubmed/24278764
http://dx.doi.org/10.6064/2012/965908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820604/
https://www.ncbi.nlm.nih.gov/pubmed/24278764
http://dx.doi.org/10.6064/2012/965908

Ejemplares similares